>
Dancann Pharma A/S logo

DANCAN TO 1 - Dancann Pharma A/S Share Price

DKK0.05 0.0  0.0%

Last Trade - 14/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £8.38m
Enterprise Value £7.73m
Revenue £n/a
Position in Universe 1667th / 1895
Bullish
Bearish
Unlock DANCAN TO 1 Revenue
Momentum
Relative Strength (%)
1m -1.40%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 0.98 14.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, DancannPharma A/S revenues was not reported. Net loss increasedfrom DKR1.7M to DKR4.6M. Higher net loss reflects OtherExternal Expense increase from DKR1.1M to DKR3.6M (expense), Personnel Expenses increase from DKR377K to DKR2.6M(expense), Depreciation increase from DKR5K to DKR230K(expense). Basic Earnings per Share excluding ExtraordinaryItems decreased from -DKR0.08 to -DKR0.23.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DANCAN TO 1 Revenue Unlock DANCAN TO 1 Revenue

Net Income

DANCAN TO 1 Net Income Unlock DANCAN TO 1 Revenue

Normalised EPS

DANCAN TO 1 Normalised EPS Unlock DANCAN TO 1 Revenue

PE Ratio Range

DANCAN TO 1 PE Ratio Range Unlock DANCAN TO 1 Revenue

Dividend Yield Range

DANCAN TO 1 Dividend Yield Range Unlock DANCAN TO 1 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DANCAN TO 1 EPS Forecasts Unlock DANCAN TO 1 Revenue
Profile Summary

Dancann Pharma A/S is a Denmark-based pharmaceutical biotechnology company powered by cannabinoids. The Company is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma manufactures and distributes prescription drugs (Rx drugs) and over-the-counter drugs (OTCs), mainly focused on pain patients with alternative needs.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 20,730,800
Free Float (0.0%)
Eligible for
ISAs
SIPPs
6823
View larger map
+
Address Rugvaenget 5, ANSAGER, 6823, Denmark
Web
Phone +
Auditors BDO Statsautoriseret Revisionsaktieselskab
DANCAN TO 1 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DANCAN TO 1
Upcoming Events for DANCAN TO 1
Frequently Asked Questions for Dancann Pharma A/S
What is the Dancann Pharma A/S share price?

As of 14/09/21, shares in Dancann Pharma A/S are trading at DKK0.05, giving the company a market capitalisation of £8.38m. This share price information is delayed by 15 minutes.

How has the Dancann Pharma A/S share price performed this year?

Shares in Dancann Pharma A/S are currently trading at DKK0.05 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dancann Pharma A/S price has moved by % over the past year.

What are the analyst and broker recommendations for Dancann Pharma A/S?

There are no analysts currently covering Dancann Pharma A/S.

When will Dancann Pharma A/S next release its financial results?

Dancann Pharma A/S is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Dancann Pharma A/S dividend yield?

Dancann Pharma A/S does not currently pay a dividend.

Does Dancann Pharma A/S pay a dividend?

Dancann Pharma A/S does not currently pay a dividend.

When does Dancann Pharma A/S next pay dividends?

Dancann Pharma A/S does not currently pay a dividend.

How do I buy Dancann Pharma A/S shares?

To buy shares in Dancann Pharma A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dancann Pharma A/S?

Shares in Dancann Pharma A/S are currently trading at DKK0.05, giving the company a market capitalisation of £8.38m.

Where are Dancann Pharma A/S shares listed? Where are Dancann Pharma A/S shares listed?

Here are the trading details for Dancann Pharma A/S:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: DANCAN TO 1
What kind of share is Dancann Pharma A/S?

Based on an overall assessment of its quality, value and momentum, Dancann Pharma A/S is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Dancann Pharma A/S share price forecast 2021?

Shares in Dancann Pharma A/S are currently priced at DKK0.05. At that level they are trading at 13.6% discount to the analyst consensus target price of 0.00.

Analysts covering Dancann Pharma A/S currently have a consensus Earnings Per Share (EPS) forecast of -0.6597091511 for the next financial year.

How can I tell whether the Dancann Pharma A/S share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dancann Pharma A/S. Over the past six months, the relative strength of its shares against the market has been -86.83%. At the current price of DKK0.05, shares in Dancann Pharma A/S are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dancann Pharma A/S PE Ratio?

We were not able to find PE ratio data for Dancann Pharma A/S.

Who are the key directors of Dancann Pharma A/S?

We were unable to find the directors for Dancann Pharma A/S.

Who are the major shareholders of Dancann Pharma A/S?

Here are the top five shareholders of Dancann Pharma A/S based on the size of their shareholding:

Similar to DANCAN TO 1
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.